🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

148,46 USD

Máx. histórico

156,92

14 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-5,39%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,24%

Cierre anterior

150,33

Rango de hoy

146,28 – 149,59

Volumen hoy

10.884.998

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
118,77 (puede no estar actualizado)
Dividend yield
2,26% (puede no estar actualizado)
Precio objetivo analistas
150,42 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 1 hora
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,26%
Fecha de pago Importe por participación
12/03/2015 0,4294 USD
11/12/2014 0,4294 USD
11/09/2014 0,4198 USD
12/06/2014 0,4198 USD
13/03/2014 0,4198 USD
12/12/2013 0,4198 USD
12/09/2013 0,4103 USD
13/06/2013 0,4103 USD
13/03/2013 0,4103 USD
13/12/2012 0,4103 USD
13/09/2012 0,4008 USD
13/06/2012 0,4008 USD
13/03/2012 0,4008 USD
13/12/2011 0,4008 USD
13/09/2011 0,3626 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
23/04/1993 16,76 17,18 16,76 17,18 +2,49% 2,49% 4.221.973
22/04/1993 17,53 17,53 16,64 16,76 -4,42% 5,10% 5.922.667
21/04/1993 17,89 17,89 17,47 17,53 -2,00% 2,33% 5.588.355
20/04/1993 17,35 17,89 17,24 17,89 +4,53% 3,78% 10.699.661
19/04/1993 16,22 17,18 16,22 17,12 +5,51% 5,88% 6.634.469
16/04/1993 15,86 16,22 15,74 16,22 +2,64% 3,01% 7.692.320
15/04/1993 16,10 16,16 15,74 15,80 -1,85% 2,59% 6.165.803
14/04/1993 16,22 16,28 16,04 16,10 -0,37% 1,47% 4.122.832
13/04/1993 16,40 16,58 16,04 16,16 -1,09% 3,27% 5.888.502
12/04/1993 15,86 16,46 15,80 16,34 +3,40% 4,14% 6.136.878
08/04/1993 16,22 16,22 15,74 15,80 -2,21% 2,94% 6.203.950
07/04/1993 16,10 16,34 16,04 16,16 +0,00% 1,85% 5.065.403
06/04/1993 16,22 16,34 16,04 16,16 -0,73% 1,84% 5.239.371
05/04/1993 16,52 16,52 16,10 16,28 +0,37% 2,53% 6.395.734
02/04/1993 16,34 16,40 16,10 16,22 -1,09% 1,82% 8.983.456
01/04/1993 16,76 16,82 16,40 16,40 -2,83% 2,49% 8.121.581
31/03/1993 17,41 17,65 16,70 16,88 -1,39% 5,48% 11.701.968
30/03/1993 16,58 17,18 16,34 17,12 +3,99% 5,04% 8.565.304
29/03/1993 16,34 16,64 16,16 16,46 +1,47% 2,92% 8.029.357
26/03/1993 16,88 16,94 16,10 16,22 -4,23% 4,95% 11.526.323
25/03/1993 16,52 17,06 16,34 16,94 +2,16% 4,33% 9.452.122
24/03/1993 16,16 16,70 15,86 16,58 -6,08% 5,17% 27.385.288
23/03/1993 17,24 17,89 17,24 17,65 +3,50% 3,81% 6.755.618
22/03/1993 17,06 17,18 16,70 17,06 -1,04% 2,80% 8.886.830
19/03/1993 17,41 17,47 17,06 17,24 -0,69% 2,40% 10.742.838
18/03/1993 17,47 17,53 17,24 17,35 -0,68% 1,71% 9.795.656
17/03/1993 17,89 17,95 17,35 17,47 -2,98% 3,33% 8.458.618
16/03/1993 18,19 18,31 17,89 18,01 -2,27% 2,30% 5.051.360
15/03/1993 18,79 18,85 18,37 18,43 -1,28% 2,54% 3.410.192
12/03/1993 18,37 18,73 18,19 18,67 -0,32% 2,92% 4.439.538